Anti-PD-1 Therapy-Associated Type 1 Diabetes in a Pediatric Patient With Relapsed Classical Hodgkin Lymphoma.
Raynald A SamoaHayley S LeeSung H KilBart O RoepPublished in: Diabetes care (2020)
The expanded ICI use may lead to more cases in pediatric patients as has been observed in adults. Considering the acute manifestation of diabetes and the added burden of lifelong insulin therapy, in particular for pediatric patients and their families, monitoring and education of ICI-associated diabetes in children is needed.
Keyphrases
- type diabetes
- hodgkin lymphoma
- glycemic control
- cardiovascular disease
- healthcare
- liver failure
- acute lymphoblastic leukemia
- insulin resistance
- young adults
- acute myeloid leukemia
- risk factors
- diffuse large b cell lymphoma
- metabolic syndrome
- weight loss
- multiple myeloma
- skeletal muscle
- extracorporeal membrane oxygenation
- replacement therapy